GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Chimin Health Management Co 603222.SS · CNY

Health Care · Shanghai · 🇨🇳 China

Compare

7.03

+0.14%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Chimin Health Management Co

Its shares trade on Shanghai under the ticker 603222.SS. It has been listed since 17 February 2015. In the fiscal year to 31 December 2025, it reported revenue of CN¥686.0m and a net loss of CN¥245.6m. At that date it held total assets of CN¥2.31bn and shareholders' equity of CN¥1.22bn.

Chimin Health Management Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Taizhou, Zhejiang. The company went IPO on 2015-02-17. The firm primarily produces Non Polyvinyl chloride (PVC) soft bag infusion products, plastic bottle infusion products, as well as injection and puncture machinery products, including safety syringe, sterile syringes and infusion sets. The firm distributes its products within domestic market and to overseas markets.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
17 Feb 2015
Employees
1,851
Website
chimin.cn ↗

Leadership

Pay as last reported

  • Huihui LiChairman of the Board
  • Mr. Guowei YangChief Financial Officer
  • Mr. Gaopeng QiuExecutive Vice President, Director
  • Mr. Kun ChenVice President, Secretary of the Board, Director, since 2022
  • Mr. Yong BieVice President
  • Ms. Qinghong HeVice President
  • Mr. Yunfei TianGeneral Manager, Director
  • Jing LiDeputy General Manager
  • Mr. Tairong LiangDeputy General Manager
  • Guiyan MaDeputy General Manager
  • Mr. Bin ZhangDeputy General Manager
  • Yu HuangDirector

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Chimin Health Management Co Ltd employs 1,851 full-time employees in Taizhou, Zhejiang.
  • The company produces Non PVC soft bag infusion products for domestic and overseas markets.
  • Chimin's product portfolio includes safety syringes and sterile syringes for healthcare use.

Weaknesses

  • Chimin's business is limited to pharmaceutical manufacturing without diversification.
  • The company relies solely on domestic and overseas market distribution channels.
  • Chimin has no mention of R&D investment in its business description.

Opportunities

  • Expanding into the growing Chinese pharmaceutical market with 1,851 employees.
  • Increasing demand for Non PVC soft bag infusion products in healthcare sectors.
  • Potential growth in overseas markets for Chimin's injection and puncture machinery.

Threats

  • Competition from other pharmaceutical manufacturers in the Chinese market.
  • Regulatory changes affecting pharmaceutical product manufacturing in China.
  • Dependence on domestic market for a significant portion of revenue.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.